Excelsior Biopharma Inc(TW:6496)
NT$23.65-0.20 (-0.84%)
TW:6496
Excelsior Biopharma Inc Revenue
NT$23.65
At close:-0.20 (-0.84%)
Excelsior Biopharma Inc (6496) Revenue
Excelsior Biopharma Inc Revenue
Excelsior Biopharma Inc had a revenue of 232.49M in the quarter ending Jun 30, 2026, with 6.62%. This bring the company's revenue in the last twelve months to 936.92M, Increased 3.36%. In the fiscal year ending Dec 31, 2025, Excelsior Biopharma Inc had annual revenue of 898.26M with 4.22% growth.
- Revenue (ttm)
- 936.92M
- Revenue Growth
- 11.64%
- P/S Ratio
- 1.25
- Revenue/Employee
- TWD 59,884,200
- Employees
- 15
- Market Cap
- TWD 1.13B
Revenue Chart
Excelsior Biopharma Inc Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 898.26M | 36.35M | 4.22% |
| Dec 31, 2024 | 861.91M | 90.35M | 11.71% |
| Dec 31, 2023 | 771.56M | 99.80M | 14.86% |
| Dec 31, 2022 | 671.76M | -666.63M | -49.81% |
| Dec 31, 2021 | 1.34B | -105.27M | -7.29% |
| Dec 31, 2020 | 1.44B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.